Alexion Pharmaceuticals Inc. (ALXN)
A global biopharmaceutical company focussed on alleviating or eradicating rare diseases in patients. The company serves patients in ca. 50 countries and is headquartered in Connecticut, USA. Their breakthrough product, Soliris ®, is used to treat two extremely rare, life threatening disorders. Alexion has been added to both the NASDAQ-100 and S&P 500 indices.
- Pharmaceuticals & Biotechnology
- 🇺🇸 United States
- $125.91 yesterday's close
52 Week High0.0%17 April 2019
52 Week Low0.0%17 April 2019
Next Ex-Div-Date Countdown
|Ex-Div Date||Pay Date||Year||Type||Frequency||Status||Amount|
Alexion Pharmaceuticals Inc. optimized dividend - 12 month history
Alexion Pharmaceuticals Inc. share price - 12 month history
Try the real thing now:
You currently don't have access this feature, however you can preview the functionality.
This is a fully-functional demo intended to showcase the usefulness of this product using old data.
By proceeding you acknowledge that shown here is old data for demonstration purposes only.
To immediately activate your free account and see the live data you can log in with Facebook or LinkedIn: